These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16557225)

  • 1. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Laplante K; Asplin JR
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
    Li Q; Krieger NS; Yang L; Asplin J; Bushinsky DA
    Nephron; 2024; 148(7):480-486. PubMed ID: 38262368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Grynpas MD; Asplin JR
    Kidney Int; 2001 Apr; 59(4):1415-23. PubMed ID: 11260403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25(OH)ā‚‚Dā‚ƒ-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Krieger NS; Culbertson CD; Asplin DM; Bushinsky DA
    Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1132-8. PubMed ID: 23926184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Michalenka AC; Strutz KL; Donahue S; Asplin JR
    Kidney Int; 2008 Feb; 73(4):423-9. PubMed ID: 18046318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.
    Yao JJ; Bai S; Karnauskas AJ; Bushinsky DA; Favus MJ
    J Am Soc Nephrol; 2005 May; 16(5):1300-8. PubMed ID: 15788476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
    Frick KK; Asplin JR; Favus MJ; Culbertson C; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F718-26. PubMed ID: 23344574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
    Asplin JR; Bushinsky DA; Singharetnam W; Riordon D; Parks JH; Coe FL
    Kidney Int; 1997 Mar; 51(3):640-5. PubMed ID: 9067894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Willett T; Asplin JR; Culbertson C; Che SP; Grynpas M
    J Bone Miner Res; 2011 Aug; 26(8):1904-12. PubMed ID: 21351146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats.
    Bushinsky DA; Kim M; Sessler NE; Nakagawa Y; Coe FL
    Kidney Int; 1994 Jan; 45(1):58-65. PubMed ID: 8127022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Frick KK; Nehrke K
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):403-18. PubMed ID: 16775455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.